Dihydromyricetin protects against lipopolysaccharide‑induced cardiomyocyte injury through the toll‑like receptor‑4/nuclear factor‑κB pathway. [electronic resource]
Producer: 20180622Description: 8983-8988 p. digitalISSN:- 1791-3004
- Animals
- Cardiotonic Agents -- pharmacology
- Cell Line
- Cell Survival -- drug effects
- Flavonols -- pharmacology
- Gene Expression Regulation -- drug effects
- Inflammation -- genetics
- Inflammation Mediators -- metabolism
- Lipopolysaccharides
- Myocytes, Cardiac -- drug effects
- NF-kappa B -- metabolism
- RNA, Messenger -- genetics
- Rats
- Signal Transduction -- drug effects
- Toll-Like Receptor 4 -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.